Tag: physical

Improve Your Fitness and Financial Life in 2024 With These WSJ Challenges
Money

Improve Your Fitness and Financial Life in 2024 With These WSJ Challenges

Updated Jan. 2, 2024 9:28 am ETIn the past few years, The Wall Street Journal launched six email challenges to help our readers get better at something in their lives, from fitness to money. Each free challenge starts when you sign up, and continues with one email a week to your inbox—full of exercises and how-tos—for four to six weeks.For 2024, we’ve updated and refreshed these short courses for those looking for a project or challenge to kick off the year. While we don’t recommend doing all six challenges at once, we do recommend taking advantage of the fresh-start energy the new year brings and making plans for joy in January.Copyright ©2024 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Yelp, Strava and Duolingo Are…Dating Apps?
Technology

Yelp, Strava and Duolingo Are…Dating Apps?

On the internet, every app can be a dating app.Just ask Strava user Courtney Hollingsworth. She has long used the exercise-tracking app Strava to log her runs and workouts, and leave kudos and comments for fellow athletes. Two years ago, she also used it to let a fellow runner know she was single and interested.Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Yelp, Strava and Duolingo Are…Dating Apps?
World

Yelp, Strava and Duolingo Are…Dating Apps?

On the internet, every app can be a dating app.Just ask Strava user Courtney Hollingsworth. She has long used the exercise-tracking app Strava to log her runs and workouts, and leave kudos and comments for fellow athletes. Two years ago, she also used it to let a fellow runner know she was single and interested.Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Novo Nordisk’s Wegovy Shows Heart Benefits Beyond Weight Loss, New Data Suggests
World

Novo Nordisk’s Wegovy Shows Heart Benefits Beyond Weight Loss, New Data Suggests

The effectiveness of Novo Nordisk’s blockbuster obesity treatment Wegovy in reducing heart attacks and strokes could be due to more than weight loss alone, according to new clinical trial data.The surging popularity of the drug has seen the Danish pharmaceutical giant scramble to boost production as it struggles to meet demand. It has been forced to limit supply of lower-strength doses of Wegovy in the U.S. as it seeks to safeguard supplies for current patients, and has outlined plans to invest more than $6 billion to boost production capacity.Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
Novo Nordisk Earnings Continue to Surge on Blockbuster Weight-Loss Drug Demand
World

Novo Nordisk Earnings Continue to Surge on Blockbuster Weight-Loss Drug Demand

Updated Nov. 2, 2023 3:27 am ETNovo Nordisk’s earnings soared by 56% in the third quarter, boosted by blockbuster weight-loss drugs that have quickly made the Danish drugmaker Europe’s most valuable company.However, the company said it will continue to restrict the supply of lower-strength doses of its Wegovy obesity medicine in the U.S. to safeguard supplies for current patients.Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8
The ‘Ozempic Effect’ on Wall Street Has Gone Overboard
World

The ‘Ozempic Effect’ on Wall Street Has Gone Overboard

Updated Nov. 1, 2023 4:39 pm ETAmerica leads developed nations when it comes to obesity. Those paying close attention to the stock market and recent corporate earnings calls might be forgiven for thinking the problem has been solved.Call it the Ozempic effect. A new generation of highly effective weight-loss and diabetes drugs known as GLP-1s has led to fanciful assumptions on Wall Street that spell doom for companies that have profited from America’s obesity problem. It has also led to speculation that gigantic opportunities await those that would benefit from the aggregate weight loss.Copyright ©2023 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8